MDMA designated as ‘breakthrough therapy’
In a press release dated 26 August 2017, the Multidisciplinary Association for Psychedelic Studies (MAPS) announced that the US Food and Drug Administration has granted ‘Breakthrough Therapy’ designation for MDMA-assisted psychotherapy for PTSD.
TEDx: The Psychedelic Renaissance
Dr Stephen Bright speaking at TEDx UniMelb on the psychedelic renaissance.
MDMA could help treat veterans with PTSD, scientists say
Scientists believe the illegal drug MDMA, also known as ecstasy, has an untapped potential to treat post-traumatic stress disorder (PTSD). But they say plans to test the drug on war veterans in Australia are being stifled by “academic conservatism”. Current treatments for PTSD sufferers can involve a person being exposed to their trauma for weeks […]
EGA 2017 Outdoor Psychedelic Symposium
PRISM is a proud sponsor of the Entheogenesis Australis 2017 Outdoor Psychedelic Symposium. For over a decade Entheogenesis Australis has provided a major meeting place for ethnobotanical enthusiasts and specialists in Australia to share information and create community. The aims of the EGA conference are to address the issues relating to drug use from social, cultural […]
A Critical Analysis of Psychedelics and Psychology
This presentation was delivered by PRISM Vice-President Dr Stephen Bright at a fundraising seminar and dinner held at The Melbourne Brain Centre, Parkville on 8th April 2016.
Psychedelic medical research in Australia: The long and winding road
This presentation was delivered by PRISM President Dr Martin Williams at a fundraising seminar and dinner held at The Melbourne Brain Centre, Parkville on 8th April 2016.
Reflections on Beyond Psychedelics 2016
PRISM Vice President Dr Stephen Bright reflects on his attendance as a guest speaker at Beyond Psychedelics 2016 in Prague.
The Psychedelia Podcast: Interview with Stephen Bright
Dr Stephen Bright talks to The Psychedelia Podcast about the problems facing the psychedelic movement in Australia
The Project on microdosing & MDMA therapy
The Project covers Microdosing & MDMA therapy with Dr Stephen Bright (NDRI & PRISM)
Interview with Dr Bright on psychedelic psychotherapy
Dr Stephen Bright, a Psychologist working at Curtin University discusses psychedelic therapy.
MDMA Can Cure PTSD
Paul Gregoire from Sydney Criminal Lawyers spoke with PRISM’s Dr Stephen Bright about treating PTSD with MDMA-assisted therapy.
Interview with Dr Williams on ABC Radio Alice Springs
Dr Martin Williams, president of Psychedelic Research in Science & Medicine talks on ABC Radio Alice Springs
How might MDMA be used to treat post-traumatic stress disorder?
MDMA — more commonly known as ecstasy — is one step closer to becoming a legal form of treatment for post-traumatic stress disorder (PTSD) in the United States.
Interview with Dr Bright on ABC 720
An interview with Dr Stephen Bright on why Australia needs to mount a clinical trial of MDMA-assisted therapy sooner rather than later.
Beyond Harm Reduction: Acknowledging the Benefits of Drug Use
In September 2016 PRISM’s Vice President Dr Stephen Bright spoke at Beyond Psychedelics, a global multidisciplinary psychedelic forum held in Prague, Czech Republic.
Tweets
- RT @tookwancottage : Which is not always easy in intolerant and/or bigoted/judgmental societies, @PRISMNews , @AODMediaWatch et al. https://t… 5 hours ago
- RT @PRISMNews : If you’re an ayahuasca drinker, this global survey is for you https://t.co/N0H7rHuUgI 5 hours ago
- ‘The best way to assist people with drug problems is to help them reintegrate into society ‘ @stephenjbright https://t.co/GdMmFG5Lda 5 hours ago
- Australia’s media don’t understand the medical potential of psychedelics, says Psychiatrist Dr Nigel Strauss https://t.co/q5WdOGLPSm 6 hours ago
PRISM Inc (ABN 96 575 647 082) is registered as a charity with the Australian Charities and Not-for-profits Commission ABN 96 575 647 082.
All donations over $2 are tax deductible in Australia.